A carbamate and thiazole derivative that functions as a CYTOCHROME P450 CYP3A INHIBITOR to enhance the concentration of ANTI-HIV AGENTS, with which it is used in combination, for the treatment of HIV INFECTIONS.
Cobicistat has been studied across 12 research domains including 🫘 Kidney, 🔬 Oncology, 🧠 Focus & Attention, 🫁 Liver & Detox, 🦴 Bone & Joint. The primary research focus is 🫘 Kidney with 8% of studies addressing this area.
The following compounds share molecular targets with Cobicistat, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Cobicistat is generated deterministically from 293 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.